Nishimura Junji
Division of Molecular Cardiology, Research Institute of Angiocardiology, Graduate School of Medical Sciences, Kyushu University, Japan.
J Pharmacol Sci. 2006 Sep;102(1):27-31. doi: 10.1254/jphs.fmj06002x5.
Many kinds of vasodilators induce relaxation of the vascular smooth muscle cells (VSMCs) through the production of cyclic AMP (cAMP) or cyclic GMP (cGMP). The relaxant effects mediated by these second messengers are thought to be mainly due to the decrease in intracellular Ca(2+) concentration (Ca(2+)), as well as the decrease in Ca(2+) sensitivity of the contractile apparatus of VSMCs. To explain the cAMP- or cGMP-mediated decrease in Ca(2+), several mechanisms have been proposed, including the inhibition of Ca(2+) influx due to a hyperpolarization, a stimulation of Ca(2+) uptake into the intracellular store, and an increase in Ca(2+) extrusion from VSMCs by stimulation of sarcolemmal Ca(2+)-pump. VSMCs have two major systems for Ca(2+) extrusion, namely, sarcolemmal Ca(2+)-pump and Na(+)/Ca(2+) exchanger (NCX). However, the involvement of NCX in the vasodilator-induced relaxation of VSMCs has not been well established. In this article, the possible involvement of NCX in the vasodilator-induced relaxation of VSMCs will be reviewed.
许多种类的血管舒张剂通过产生环磷酸腺苷(cAMP)或环磷酸鸟苷(cGMP)来诱导血管平滑肌细胞(VSMC)舒张。由这些第二信使介导的舒张作用被认为主要是由于细胞内钙离子浓度([Ca(2+)]i)降低,以及VSMC收缩装置对钙离子的敏感性降低。为了解释cAMP或cGMP介导的[Ca(2+)]i降低,人们提出了几种机制,包括由于超极化抑制钙离子内流、刺激钙离子摄取到细胞内储存库以及通过刺激肌膜钙离子泵增加VSMC的钙离子外流。VSMC有两种主要的钙离子外流系统,即肌膜钙离子泵和钠/钙交换器(NCX)。然而,NCX在血管舒张剂诱导的VSMC舒张中的作用尚未得到充分证实。在本文中,将综述NCX在血管舒张剂诱导的VSMC舒张中可能的作用。